Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Ambady

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Neuro-Oncology|October 3, 2018
Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogressionRamon F Barajas, Bronwyn E Hamilton, Daniel Schwartz, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Kidney International|April 25, 2017
Current and potential imaging applications of ferumoxytol for magnetic resonance imagingGerda B Toth, Csanad G Varallyay, Andrea Horvath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform NeurofibromaChristopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, et al.
AJNR. American Journal of Neuroradiology|December 1, 2025
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with GlioblastomaJana Ivanidze, Kellen Vo Vu, Rongwei Fu, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Neuro-Oncology|October 3, 2018
Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogressionRamon F Barajas, Bronwyn E Hamilton, Daniel Schwartz, et al.
Neuro-Oncology|February 9, 2021
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG)Ramon F Barajas, Letterio S Politi, Nicoletta Anzalone, et al.
Kidney International|April 25, 2017
Current and potential imaging applications of ferumoxytol for magnetic resonance imagingGerda B Toth, Csanad G Varallyay, Andrea Horvath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform NeurofibromaChristopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, et al.
AJNR. American Journal of Neuroradiology|December 1, 2025
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with GlioblastomaJana Ivanidze, Kellen Vo Vu, Rongwei Fu, et al.
Pageof 4